The kidney–thrombosis connection in chronic kidney disease through a meta‐analysis of arterial and venous thrombotic events

Background Chronic kidney disease (CKD) is increasingly recognized as a prothrombotic condition; however, the magnitude of the risk of arterial and venous thrombosis in patients with CKD remains uncertain. This systematic review aimed to synthesize the evidence on arterial and venous thrombotic events in patients with CKD compared with controls. Methods The review was prospectively registered on PROSPERO (CRD420261473453) and conducted following the PRISMA guidelines. Four databases (CENTRAL, PubMed, PubMed Central, and Google Scholar) were searched up to 4 August 2026. Fourteen observational studies involving 1,836,579 individuals from nine countries were included in the systematic review, of which seven contributed to the meta-analysis. Unadjusted risk ratios (RRs) with 95% confidence intervals (CIs) for composite venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism were calculated from raw event counts and pooled using random-effects meta-analysis (restricted maximum likelihood with Hartung–Knapp adjustment). Results In the narrative synthesis, studies with a comparator group consistently reported a higher risk of venous thrombosis with lower kidney function, ranging from a moderate increase in adjusted risk in mild-to-moderate CKD (adjusted hazard ratio [aHR] 1.54–1.71) to a markedly higher risk of DVT in end-stage kidney disease (ESKD) requiring dialysis (aHR 13.92 in one cohort). Arterial outcomes were reported by only three studies, none of which compared incident arterial events between patients with and without CKD. In the pooled analysis of unadjusted RRs, the estimate for composite VTE (6 studies; 954,129 participants) was 2.06 (95% CI 0.41 to 10.23; I 2 = 99.2%), for DVT (3 studies; 17,562 participants) 9.52 (95% CI 0.43 to 210.24; I 2 = 95.0%), and for pulmonary embolism (2 studies; 8,904 participants) 3.48 (95% CI 0.14 to 88.84; I 2 = 0%). None reached statistical significance (p > 0.05), and the certainty of evidence was low for all outcomes. Conclusion Observational studies on an individual level showed that the risk of venous thrombosis increases as renal function deteriorates, but the summary estimates without adjustment were very imprecise and heterogeneous, and there was low certainty of evidence. The effect size of the risk of developing thrombosis in CKD is unclear currently, and highquality studies employing uniform criteria for the diagnosis of CKD and thrombotic outcomes are warranted.

Authors

Institutions

Publication Details

Journal
Frontiers in Molecular Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fmmed.2026.1978556
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The kidney–thrombosis connection in chronic kidney disease through a meta‐analysis of arterial and venous thrombotic events

Kavin Sharma, Amrendra K. Ajay, Deepthi Sree Vamaraju, Arjun Sharma et al.
Frontiers in Molecular Medicine
Venous Thromboembolism Diagnosis and Management
article

The kidney–thrombosis connection in chronic kidney disease through a meta‐analysis of arterial and venous thrombotic events

Kavin Sharma, Amrendra K. Ajay, Deepthi Sree Vamaraju, Arjun Sharma, Bharat Sharma, Anmol Arora, Jude Yang Yoo
article en

Abstract

Background Chronic kidney disease (CKD) is increasingly recognized as a prothrombotic condition; however, the magnitude of the risk of arterial and venous thrombosis in patients with CKD remains uncertain. This systematic review aimed to synthesize the evidence on arterial and venous thrombotic events in patients with CKD compared with controls. Methods The review was prospectively registered on PROSPERO (CRD420261473453) and conducted following the PRISMA guidelines. Four databases (CENTRAL, PubMed, PubMed Central, and Google Scholar) were searched up to 4 August 2026. Fourteen observational studies involving 1,836,579 individuals from nine countries were included in the systematic review, of which seven contributed to the meta-analysis. Unadjusted risk ratios (RRs) with 95% confidence intervals (CIs) for composite venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism were calculated from raw event counts and pooled using random-effects meta-analysis (restricted maximum likelihood with Hartung–Knapp adjustment). Results In the narrative synthesis, studies with a comparator group consistently reported a higher risk of venous thrombosis with lower kidney function, ranging from a moderate increase in adjusted risk in mild-to-moderate CKD (adjusted hazard ratio [aHR] 1.54–1.71) to a markedly higher risk of DVT in end-stage kidney disease (ESKD) requiring dialysis (aHR 13.92 in one cohort). Arterial outcomes were reported by only three studies, none of which compared incident arterial events between patients with and without CKD. In the pooled analysis of unadjusted RRs, the estimate for composite VTE (6 studies; 954,129 participants) was 2.06 (95% CI 0.41 to 10.23; I 2 = 99.2%), for DVT (3 studies; 17,562 participants) 9.52 (95% CI 0.43 to 210.24; I 2 = 95.0%), and for pulmonary embolism (2 studies; 8,904 participants) 3.48 (95% CI 0.14 to 88.84; I 2 = 0%). None reached statistical significance (p > 0.05), and the certainty of evidence was low for all outcomes. Conclusion Observational studies on an individual level showed that the risk of venous thrombosis increases as renal function deteriorates, but the summary estimates without adjustment were very imprecise and heterogeneous, and there was low certainty of evidence. The effect size of the risk of developing thrombosis in CKD is unclear currently, and highquality studies employing uniform criteria for the diagnosis of CKD and thrombotic outcomes are warranted.

Frontiers in Molecular MedicineVol. 6
Brigham and Women's Hospital (US), Beth Israel Deaconess Medical Center (US), Children's Hospital of Philadelphia (US), Harvard University (US), National University of Singapore (SG), Yale University (US), Massachusetts Institute of Technology (US), University of Rajasthan (IN)
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon